中文     English

Regulatory strategy is the foundation for our clients to expand in the overseas market.  A solid understanding of the regulatory path for our client’s products will build an accurate timeline of growth for our clients in the target market.  Such a picture will be critical in developing a complimentary growth strategy ( including licensing and M & A) to help the company reach its target growth in the short and long term in this core growth market. 

 

Our regulatory team has extensive experience in the small molecule, large molecule, and medical device fields in the greater China area, Korea and US market.  Our strong presence in the regulatory area will help our clients develop a sound growth strategy in the target market.  

 

 

 

 


 

 

Hot Topic

Pathways to seek approval of novel drug with Chinese Food and Drug Administration (CFDA)

Link: Experience sharing for regulatory filings.pdf